Warwick researchers develop new vehicle for drug release
Plankton inspires creation of ‘stealth’ armour for slow release microscopic drug vehicles
The scientists have been able to decorate these hollow structures with a variety of nanoparticles, opening a new strategy in the design of vehicles for drug release, for example by giving the vesicle ‘stealth’ capabilities which can avoid the body’s defences while releasing the drug.
Advances in polymerisation have boosted the creation of vesicles made from polymer molecules. Such vesicles have special chemical and physical properties, which make them potential drug delivery vehicles.
The University of Warwick team believed that more strength and tailored properties could be given to the vesicles if they could add an additional layer of colloidal ‘armour’ made from a variety of nanoparticles.
Lead researcher, Associate Professor Stefan Bon, said: ‘We took our inspiration from nature, in how it adds protection and mechanical strength in certain classes of cells and organisms. In addition to the mechanical strength provided by the cytoskeleton of the cell, plants, fungi, certain bacteria have an additional cell wall as outermost boundary.
‘Organisms that particularly attracted our interest were those with a cell wall composed of an armour of colloidal objects – for instance bacteria coated with S-layer proteins, or phytoplankton, such as the coccolithophorids, which have their own CaCO3-based nano-patterned colloidal armour.’
The Warwick researchers hit on a simple and effective method of adding different types of extra armour to the polymer-based vesicles. One example was a packed layer of microscopic polystyrene balls. Because the polystyrene balls had a crystalline-like ordered structure, the researchers could design a vesicle with an additional and precise permeable reinforced barrier for drug release.
The researchers used the same technique to add a gelatine-like polymer to provide ‘stealth’ armour to shield vesicles from unwanted attention from the body’s immune system while it slowly released its drug treatment.
This particular coating (a poly((ethyl acrylate)-co-(methacrylic acid)) hydrogel) absorbs so much surrounding water into its outer structure that it may be able to fool the body’s defence mechanism into believing it is in fact just water.
You may also like
Trending Articles
You may also like
Drug Delivery
Piramal Pharma Solutions augments formulation capabilities with the addition of new Korsch XM-12 bilayer tablet press at its Morpeth, UK facility
This tablet press will provide the facility’s Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12
Research & Development
Amphista Therapeutics discloses first details of its SMARCA2 degrader programme
Amphista has identified SMARCA2 Targeted Glues, which induce protein degradation via a novel mechanism and enable the development of smaller and more drug-like molecules than conventional PROTAC binders